AtriCure Inc
(NAS:ATRC)
$
23.25
-0.515 (-2.17%)
Market Cap: 1.12 Bil
Enterprise Value: 1.12 Bil
PE Ratio: 0
PB Ratio: 2.47
GF Score: 72/100 AtriCure Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019 / 06:15PM GMT
Release Date Price:
$23.99
(-2.40%)
Jaypreet Singh Chadha
Morgan Stanley, Research Division - Research Associate
Good afternoon. Thank you all for joining us at day 1 of the Morgan Stanley Health Care Conference. My name is Jay Chadha. I'm part of the Morgan Stanley Medical Device Research Team. And today, we have AtriCure, 2 members of management. We've got Andy Wade, CFO; and Justin Noznesky, SVP of Marketing and BD.
And Andy, if that's fine with you, we can go straight to Q&A.
M. Andrew Wade
AtriCure, Inc. - Senior VP & CFO
Yes. Great. Thanks for having us. Listen, Mike expresses his regrets. He had a funeral to attend to today with his family. So wish he could be here. But hopefully, you're in good hands with us.
Questions & Answers
Jaypreet Singh Chadha;M. Andrew Wade<
Morgan Stanley, Research Division - Research Associate
Okay. Great. So look, you made this acquisition, SentreHEART, earlier this year. Maybe we can start just by talking about the strategic rationale for the deal and go from there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot